Sight DiagnosticsⓇ is a blood diagnostics company that uses machine vision and AI to transform health systems and patient outcomes through fast, convenient and accurate blood testing. Sight’s first product, ParasightTM*, has diagnosed malaria in nearly 1 million tests across 24 countries. Sight OLOⓇ, Sight’s latest blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade CBC results in minutes.
Medicover is a leading international healthcare and diagnostic services provider. Established in 1995 in response to the growing demand for high-quality healthcare services in Poland, Medicover subsequently expanded to other countries fulfilling similar needs. Today, Medicover’s largest operations are in Germany, Poland, Romania and Ukraine. Medicover provides a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities and laboratories through two divisions – Healthcare Services and Diagnostic Services.
Avisa Pharma is developing a rapid, 10-minute point of-care biomarker breath test for the detection and monitoring of pneumonia from community (CAP), hospital (HAP) and ventilator (VAP) sources. The Avisa BreathTest (ABT) is a drug/device combination for the detection of urease-producing pathogens, the most virulent and dangerous pathogens which typically require broad spectrum antibiotics. By differentiating virulent urease bacterial pathogens from other types of infections, the ABT will assist physicians in selecting appropriate treatments and combat the widespread overuse of antibiotics
Since 2003, Molzym is committed to develop innovative solutions to serve molecular biological research and reliable diagnosis of infectious diseases. Molzym’s fast and accurate CE IVD-marked broad-range molecular diagnostic solutions are culture-independent, free of reagent-borne contaminations, and applicable for the ID of pathogens from body fluids, tissue samples and swabs in just 7 hours. High quality products are also available for microbial DNA enrichment and isolation, and for molecular analysis by PCR- and NGS-based methods.
Sysmex America is lighting the way to better health with diagnostic solutions that transform the future of healthcare and contribute to healthier lives. Its innovative hematology, urinalysis and flow cytometry testing technology is reshaping the world of diagnostics across the U.S., Canada and Latin America. As a trusted global leader, Sysmex offers diagnostics that equip patients and the health care professionals who treat them with the information needed to make decisions with confidence.
EUROIMMUN is an international provider of medical laboratory products for autoimmune, infection, allergy and molecular genetic diagnostics. The company’s portfolio encompasses indirect immunofluorescence assays, ELISAs, immunoblots, radioimmunoassays, chemiluminescence immunoassays (ChLIA), molecular genetic test systems and automation technologies.
OVVI Diagnostics Srl (Ovvidx.com) is a Belgian MedTech company that develops a Point-of-Care testing solution specifically to address Women’s health issues. Our first tests under development are for improving the management of Post-Partum Hemorrhage, to help the diagnosis and prognosis of pre-eclampsia and the monitoring of fertility. They are based on an innovative and patented technology using magnetic nanoparticles as labels to detect antigens: the MIAtek® technology.
Atomo Diagnostics Limited is a medical device company supplying unique, integrated rapid diagnostic test (RDT) devices to the global diagnostic market.
Atomo’s innovative RDT platforms are designed to be used easily by both professionals and individuals self-testing at home. These all-in-one devices greatly simplify the test procedure, reducing user errors and improving test accuracy. Their unmatched usability has won the respect of frontline healthcare professionals, medical research and self-testers worldwide making Atomo the OEM partner of choice.
For more than 30 years, Medica Corporation has manufactured easy-to-use, easy-to-maintain, and affordable analyzers specifically designed for the small to medium-sized IVD testing market. Medica offers analyzer solutions for: drugs of abuse, clinical chemistry, hematology, electrolyte, and blood gas testing. Distributed through our extensive global dealer network, Medica’s product lines are used routinely worldwide where cost and ease-of-use are essential.
Vela Diagnostics is a leading provider of an automated IVD Next Generation Sequencing (NGS) workflow in the global diagnostics market. Our sample-to-result NGS and real-time PCR solutions standardize testing, improve workflows, and help to reduce cost for optimal efficiency across laboratories of all sizes.
Agdia, Inc. is the provider of the AmpliFire® portable fluorometer. AmpliFire® performs real-time amplification and detection of molecular targets with isothermal nucleic acid amplification chemistries.
As the leading provider of diagnostics in the plant pathogen sector for the past 40 years, Agdia can also help you take the next step for your research project through reagent manufacturing scale-up, lyophilization services and more.
BioFire Diagnostics offers syndromic infectious disease diagnostic solutions with several assay-specific reagent panels. Your clinic can provide more timely and accurate diagnoses with onsite testing using the BioFire® FilmArray® Panels. Each test takes just two minutes of hands-on time and one small sample, helping to streamline your workflow and provide results to your patients in about an hour.